Page 81 - Read Online

Maurizi et al. J Cancer Metastasis Treat 2021;7:35 https://dx.doi.org/10.20517/2394-4722.2021.74 Page 19 of 19

the activation of EGFR pathway. Sci Rep 2017;7:3170. DOI PubMed PMC
139. Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med 2012;18:883-91. DOI PubMed PMC
140. Tucci M, Mannavola F, Passarelli A, Stucci LS, Cives M, Silvestris F. Exosomes in melanoma: a role in tumor progression,
metastasis and impaired immune system activity. Oncotarget 2018;9:20826-37. DOI PubMed PMC
141. Maia J, Caja S, Strano Moraes MC, Couto N, Costa-Silva B. Exosome-Based Cell-cell communication in the tumor
microenvironment. Front Cell Dev Biol 2018;6:18. DOI PubMed PMC
142. Mannavola F, Tucci M, Felici C, Passarelli A, D'Oronzo S, Silvestris F. Tumor-derived exosomes promote the in vitro osteotropism
of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. J Transl Med 2019;17:230. DOI PubMed PMC
143. Saatci O, Kaymak A, Raza U, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast
cancer. Nat Commun 2020;11:2416. DOI PubMed PMC
144. Gnant M, Pfeiler G, Dubsky PC, et al. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind,
placebo-controlled trial. Lancet 2015;386:433-43. DOI PubMed
145. Hadji P, Coleman RE, Wilson C, et al. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from
a European Panel. Ann Oncol 2016;27:379-90. DOI PubMed
146. Coleman R, Finkelstein DM, Barrios C, et al. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre,
randomised, controlled, phase 3 trial. Lancet Oncol 2020;21:60-72. DOI PubMed
147. Sartor O, Coleman R, Nilsson S, et al. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-
resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol 2014;15:738-46.
DOI PubMed
148. Suominen MI, Rissanen JP, Käkönen R, et al. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone
metastasis. J Natl Cancer Inst 2013;105:908-16. DOI PubMed
149. Srivastava K, Hu J, Korn C, et al. Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic
chemotherapy limits metastatic growth. Cancer Cell 2014;26:880-95. DOI PubMed
150. Yamamoto M, Kikuchi H, Ohta M, et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic
niche. Cancer Res 2008;68:9754-62. DOI PubMed
151. Zhang H, Lu J, Liu J, Zhang G, Lu A. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem
2020;35:1322-30. DOI PubMed PMC
152. Di Pompo G, Lemma S, Canti L, et al. Intratumoral acidosis fosters cancer-induced bone pain through the activation of the
mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma. Oncotarget 2017;8:54478-96. DOI PubMed PMC
153. Hoshino A, Kim HS, Bojmar L, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell
2020;182:1044-1061.e18. DOI PubMed PMC